Treatment goals for acromegaly include normalization of biochemical variables (growth hormone [GH] and insulin-like growth factor-1 [IGF-1] levels), tumor volume reduction (when caused by a pituitary tumor), improvement of signs, symptoms and comorbidities of the disease, and minimization of long-term mortality risk [1]. This evidence concerns the gene IGF1 and acromegaly.